Edesa Biotech, Inc. (EDSA) vs Incannex Healthcare Limited (IXHL)
A side-by-side comparison of Edesa Biotech, Inc. and Incannex Healthcare Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EDSA
Edesa Biotech, Inc.
$3.78HealthcareDelayed quote: Oct 6, 2026, 2:54 PM EDT
IXHL
Incannex Healthcare Limited
$3.16HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
Total return — EDSA vs IXHL
growth of $100 · dividends reinvested · last 5yEDSA -83.4% (-30.2%/yr)IXHL -99.8% (-71.8%/yr)EDSA compounded faster over this window
Log scale — wide-divergence pair
EDSA IXHL
EDSA vs IXHL: by the numbers
- •IXHL is the larger company ($38M vs $36M market cap).
Metrics side by side
Valuation
| Metric | EDSA | IXHL |
|---|---|---|
| P/B ratio | 91.27 | 0.56 |
Profitability
| Metric | EDSA | IXHL |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -160.05% | -28.65% |
| ROIC | -166.02% | -32.18% |
Growth (annualized)
| Metric | EDSA | IXHL |
|---|---|---|
| Total return CAGR (5Y) | -39.88% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.